Comparison of Inhospital Outcomes of Surgical Aortic Valve Replacement in Hospitals With and Without Availability of a Transcatheter Aortic Valve Implantation Program (from a Nationally Representative Database)

Autor: Samir V. Patel, Abhijit Ghatak, Achint Patel, Abeel A. Mangi, Badal Thakkar, Abhishek Deshmukh, Michael W. Cleman, Nileshkumar J. Patel, Cindy L. Grines, Tamam Mohamad, Nish Patel, Ronak Bhimani, Ankit Chothani, John K. Forrest, Nilay Patel, Aashay Patel, Sunny Jhamnani, Abhishek Dave, Parth Bhatt, Shilpkumar Arora, Apurva Badheka, Sidakpal S. Panaich, Rajesh Sonani, Vikas Singh, Chirag Savani
Rok vydání: 2015
Předmět:
Zdroj: The American Journal of Cardiology. 116:1229-1236
ISSN: 0002-9149
Popis: We hypothesized that the availability of a transcatheter aortic valve implantation (TAVI) program in hospitals impacts the overall management of patients with aortic valve disease and hence may also improve postprocedural outcomes of conventional surgical aortic valve replacement (SAVR). The aim of the present study was to compare the inhospital outcomes of SAVR in centers with versus without availability of a TAVI program in an unrestricted large nationwide patient population >50 years of age. SAVRs performed on patients aged >50 years were identified from the Nationwide Inpatient Sample (NIS) for the years 2011 and 2012 using the International Classification of Diseases, Ninth Revision, Clinical Modification procedure codes. SAVR cases were divided into 2 categories: those performed at hospitals with a TAVI program (SAVR-TAVI) and those without (SAVR-non-TAVI). A total of 9,674 SAVR procedures were identified: 4,526 (46.79%) in the SAVR-TAVI group and 5,148 (53.21%) in SAVR-non-TAVI group. The mean age of the study population was 70.2 ± 0.1 years with majority (53%) of the patients aged >70 years. The mean Charlson's co-morbidity score for patients in SAVR-TAVI group was greater (greater percentage of patients were aged >80 years, had hypertension, congestive heart failure, renal failure, and peripheral arterial disease) than that of patients in SAVR-non-TAVI group (1.6 vs 1.4, p
Databáze: OpenAIRE